Lawyers

• U.S. environmentalists face a lawsuit to overturn approval of GMO salmon

  U.S. health regulators are facing a lawsuit from a coalition of environmental groups. They are seeking to overturn the government's landmark approval of a type of genetically modified salmon to be farmed for human consumption.

• U.S. FDA expands access to abortion pill in states asking limits

  The U.S. FDA decided to expand its access of the abortion pill. The move could make the pill for abortions more accessible in at least three states wanting to limit the medication.

• FDA underestimated number of fetal deaths linked to Bayer’s contraceptive

  FDA in the past said that there are five fetal deaths related to the use of Bayer's Essure contraceptive. But a new analysis report has suggested that the fetal deaths caused by the product reached 303.

• Johnson & Johnson Losses in Supreme Court; Failure To Warn Costumers Causes Them $140M

  US Supreme Court did not take Johnson and Johnson's appeal. They will lose $140m because of not adding warning signs to their products.

• Pharmacists File Petition to the US Supreme Court to Protect Their First Amendment Rights

  As the United States enacts more and more progressive laws, some secular communities protest as they claim protection for their First Amendment rights, as in the case of pharmacists forced to stock abortion-inducing pills in their pharmacies.

• FDA staff recommends Novartis copy of Amgen's Neupogen

  Staff reviewers at the U.S. Food and Drug Administration recommended approval of Novartis AG's copy of Amgen Inc's blockbuster cancer drug Neupogen.

• FDA approves Roche Ebola test for emergency use

  Roche Holding AG said U.S. health regulators have approved its Ebola test for emergency use in response to the world's worst outbreak of the disease in West Africa.

• FDA denies approval for Actavis hypertension treatment

  Generic drug maker Actavis Plc said the U.S. health regulator denied an approval for its hypertension treatment, a fixed-dose combination of nebivolol and valsartan.

• Unilever drops mayonnaise suit against Just Mayo maker

  Unilever Plc's (ULVR.L) (UNc.AS) U.S. division said it has withdrawn its lawsuit against food startup Hampton Creek over false advertising and unfair competition related to its Just Mayo product.

• FDA prices 'lost pleasure' of junk food into calorie count rule

  U.S. health regulators estimate that consumers will suffer up to $5.27 billion in "lost pleasure" over 20 years when calorie counts on restaurant menus discourage people from ordering french fries, brownies and other high-calorie favorites.

• FDA panel votes to keep severe warning on Pfizer anti-smoking drug

  Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.